09/24/2026
We are proud to unveil the best six-month treatment effects ever reported across our clinical studies on Essilor Stellest lenses.
In 6 months, Essilor Stellest 2.0 lenses* achieved interim results comparable to those previously reported after 12 months with first-generation Essilor Stellest lenses, indicating a potential accelerated treatment response** and confirming previously published findings**.
This represents an important milestone in our long-term commitment to advancing myopia management through continuous innovation and clinical research. The magnitude and speed of the treatment observed at six months are very encouraging and represent a level of response not previously seen in our Stellest clinical research.
Read more: https://bit.ly/46zxhKj
*Essilor® Stellest® 2.0 lenses are currently not available in all countries, including the United States, and have not been cleared by the FDA in the U.S.
**For references and disclaimers, please see the press release